Back to all departments
Prof. Dr. med. Lars Bullinger image

Department of oncology, haematology, and tumour immunology

Prof. Dr. med. Lars Bullinger
haematology, oncology

About the department

The department of oncology, haematology, and tumour immunology at the University Hospital Charite Berlin specialise in diagnosing and treating tumour diseases and diseases of the blood. The unit has 96 beds at its disposal and treats over 2700 inpatients and more than 8000 outpatient cases annually. The interdisciplinary team of the department is part of the Charité Comprehensive Cancer Center, mainly part of the certified visceral oncology centre, the Charite sarcoma centre and cooperates tightly with the ovarian carcinoma centre. It is worth mentioning that the haematology centre of the department is recognised for the care of lymphoma and leukaemia. In addition, the palliative care wards are a significant part of the Charité palliative care centre. Furthermore, experimental and clinical research on lymphomas and gastrointestinal tumours is carried out at the department in cooperation with the Max Delbruck Center for Molecular Medicine.

The focal points of the unit include modern evidence-based therapy for pancreas, stomach, and intestinal cancer, as hepato-biliary and oesophageal tumours. The other focus lies on the guideline-compliant treatment of leukaemia and lymphoma. Finally, it is essential to mention stem cell transplantation as a focal point of the department.

Show more

Treatment and diagnostic focus of the department

Diagnostics:

  • morphology
  • immunophenotyping
  • cytogenetics
  • molecular genetics 
  • "next-generation sequencing" (NGS)
  • computed tomography
  • PET- CT
  • laboratory tests

Lymphomas treatment:

  •  diffuse large B-cell lymphoma
  • Burkitt's lymphoma
  • follicular lymphoma (FL)
  • Hodgkin's lymphoma (HL)

Gastrointestinal tumours treatment:

  • colorectal cancer
  • pancreatic cancer
  • oesophageal carcinomas
  • gastric carcinomas

Other tumours treatment:

  • bone tumours
  • soft tissue tumours
  • renal cell carcinomas

Tumour therapy methods:

  • allogeneic blood stem cell transplantation
  • targeted therapies
  • immunotherapy
  • radiotherapy
Show more

Doctor profile

Education

  • 1992-1997 Heidelberg Medical School, Heidelberg, Germany 
  • 1998 Baylor College of Medicine, Houston, and Duke University, Durham, USA 
  • 1999 MD, Heidelberg Medical School 
  • 2000 Dr. med. (University of Heidelberg) 
  • 2008 Habilitation (University of Ulm)

Experience

  • 2011 Assistant Prof. (apl. Professor), Internal Medicine (University of Ulm) 
  • 2016 Associate Prof. (Univ. Prof., W3), Personalized Medicine (University of Ulm) 
  • 2017 Full Professor (Univ. Prof., W3), Hematology / Oncology (Charité Berlin)
  • 1999 Residency in the Department of Internal Medicine V, Hematology/Oncology (Prof. A. D. Ho), University of Heidelberg, Germany 
  • 1999-2001 Residency in the Department of Internal Medicine III (Prof. H. Döhner), University Hospital of Ulm, Ulm, Germany 
  • 2002-2003 Postdoctoral fellowship in the Department of Pathology (Prof. J. D. Pollack), Stanford University, Stanford, CA, USA (DFG scholarship) 
  • 2004-2009 Residency/Fellowship in the Department of Internal Medicine III (Prof. H. Döhner), University Hospital of Ulm, Ulm, Germany 
  • 2010 Sabbatical in the Department of Pediatric Oncology (Prof. S. A. Armstrong), Dana Farber Cancer Institute, Harvard Medical School, MA, USA 
  • 2011-2017 Attending Physician, Department of Internal Medicine III (Prof. H. Döhner), University Hospital of Ulm, Ulm, Germany 
  • 2013-2017 Head of the Oncology Section of the Department of Internal Medicine III (Prof. H. Döhner), University Hospital of Ulm, Ulm, Germany 
  • 2016-2017 Executive deputy director, Center of Internal Medicine; University Hospital of Ulm, Germany 
  • 2016-2017 Professor for Personalized Medicine (W3), Medical Faculty University of Ulm, Germany 
  • Since 2017 Director of the Department of Hematology, Oncology and Tumorimmunology (CVK), Charité University Medicine, Berlin, Germany

Awards, memberships, publications

  • 1998 DAAD scholarship 
  • 2002-2003 DFG research scholarship 
  • 2005 Franziska Kolb award for leukaemia research 
  • 2011-2014 Heisenberg scholarship (DFG) 
  • 2015 Heisenberg Professor (DFG)
  • American Society of Hematology (ASH) 
  • American Association for Cancer Research (AACR) 
  • Arbeitsgemeinschaft Internistische Onkologie (AIO) 
  • Deutsche Gesellschaft für Hämatologie und Onkologie (DGHO) 
  • Deutschen Krebsgesellschaft (DKG) 
  • European Hematology Association (EHA) 
  • European LeukemiaNet (ELN)
Show more
Send request
Have any questions? Get in touch with the hospital!
Phone

Similar hospitals